The Role of Extracellular Vesicles in Cell Death and Inflammation
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 342
Special Issue Editor
Special Issue Information
Dear Colleagues,
Extracellular vesicles (EVs) are nanometer (nm)-scaled, membrane-bound particles that are released into circulation by most known mammalian cells. The term ‘extracellular vesicles’ is an umbrella term used to describe lipid-bound spherical particles of varied diameters which include: a) microvesicles (10–1000 nm), b) exosome (30–150 nm) and c) apoptotic bodies (50–5000 nm). Additionally, they are categorized based on their cellular or tissue source of origin. Though EVs were initially thought of as carriers of cellular waste products, a couple decades worth of research has demonstrated that they are capable of carrying signaling molecules that bring about cell-to-cell communication thus proposing a more sophisticated role for EVs. Recently, they have been touted as carriers of biomarkers to identify potential diseases. Not to mention, they continue to be characterized and assigned novel roles as we learn more about these EVs.
The significance of EVs in neurological disorders is a rapidly emerging field where research has been conducted to identify them as disease promoters and as biomarkers carrying diagnostic potential. For this Special Issue, we invite reviews or original research articles that describe the roles of EVs under normal and pathophysiological brain diseases. We will also accept articles addressing the significance of EVs in neurological inflammation and apoptosis.
Dr. Akshata Naik
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
